BP000131-CYT-396: Recombinant Porcine Interleukin-1 alpha (IL-1α) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of D10S cells is < 0.03 ng/ml.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP002449-CYT-050: Recombinant Human Interleukin-23 (IL 23) Protein
Source: HEK-derived.
The activity, as determined by the dose dependent secretion of h-IFN-g from human PBMC was found to be 2 to 20 ng/ml ED50.
Purity: > 95.0% as determined by analysis by SDS-PAGE.BP002449-CYT-067: Recombinant Human Interleukin-23 (IL 23), His Tag Protein
Source: HEK 293 cells-derived.
Purity: > 90.0% as determined by analysis by SDS-PAGE.BP002671-PRO-1086: Recombinant Mouse Immunoglobulin heavy chain gamma polypeptide (Ighg) protein
Source: Hi-5 cells-derived.
Purity: > 90% by SDS-PAGE.BP002671-PRO-1087: Recombinant Mouse Immunoglobulin heavy chain gamma polypeptide (Ighg) protein
Source: Hi-5 cells-derived.
Purity: > 90% by SDS-PAGE.BP000087-CYT-478: Recombinant Human Interferon-γ (IFNγ) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000447-HIV-141: Recombinant HTLV-1 gp21
Source: E. coli-derived.
Purity > 95%, by 10% PAGE and RP-HPLC.
Applications: WB, ELISABP000447-HIV-144: Recombinant HTLV-1 Mosaic
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HTLV-I and HTLV-II infected individuals with antibody response to HTLV envelope.
Purity > 95%, by 10% PAGE and RP-HPLC.
Applications: WB, ELISA.BP000447-HIV-142: Recombinant HTLV-I gp46 Mosaic
Source: E. coli-derived.
Purity > 95%, by 10% PAGE and RP-HPLC.
Applications: WB, ELISABP002311-HSP-105: Recombinant Human Heat Shock Protein 105 (HSPH1)
Source: E. coli-derived.
Purity: > 90.0% as determined by SDS-PAGE.